The Glucometer


Our mission is to spread awareness about diabetes and to help improve the lives of those afflicted and influenced, one life at a time.


There were ten choices of the most common glucometers on the market.

Accu Check - Rochelink

Ascensia - Bayer link

Control - U.S. Diagnostics link

FreeStyle - Abbott Labs link

One Touch - LifeScanlink

Precision Xtra - Abbott Labs link

Prestige IQ - Home Diagnostics link

Prodigy - Diagnostic Devices

Sidekick - Home Diagnostics link

Other - for any brand not included in the list

GLUCOMETERS: An Introduction


A glucometer is a glucose monitor used to measure the amount of sugar in the blood. Type 1 and Type 2 diabetics need to monitor their sugar intake, so they don't experience blood-sugar highs and lows. Most diabetics test their sugar one to four times a day. The glucometer has two parts: the lancet device for pricking the finger and the meter for measuring the blood droplet. As well as the two devices, there are lancets or needles for the lancet device and test strips that absorb the blood for meter readings.

Glucometers are many and varied. The more expensive modelsm such as the UltraSmart by Lifescan, collect data and create charts so your can analyze your sugar readings. You can also take averages weekly and monthly, as well as after eating and before eating. Simpler meters read the blood-sugar level and store the data.


You usually take blood samples from the fingers for the most accurate readings. Wash your hands with warm, soapy water. Rub an alcohol prep pad on the finger you intend to prick. Massage the finger so the blood flows to the tip. Cock the lancing device so the needle is ready. Push the lancet down onto the finger and push the button to release the needle. The needle will create a small prick on the fingertip. Continue to massage the finger until a round droplet of blood appears. Place the testing strip into the meter. This turns the meter on. Place the meter strip under the droplet, so the blood is drawn onto the strip and into the meter. It takes five seconds for the meter to read the blood and display the results.


The test strip for the glucometer contains an enzyme electrode called glucose oxidase that reacts when the blood draws into the strip. The glucose meter translates the reaction into numerals. These numerals indicate milligrams per deciliter. Normal readings before a meal are 70 to 120mg/dL. Readings after a meal should be under 180mg/dL. Readings below 70mg/dL indicate hypoglycemia or low blood sugar. Readings above 180mg/dL indicate hyperglycemia, or high blood sugar. Newer glucometers are capable of taking readings from the forearm, though the most accurate readings are from the fingers. 



Eli Lilly announced July 6, 2005, that it is discontinuing production of Iletin II Pork Insulin (Regular and NPHformulations), HumulinU Ultralente, and HumulinL Lente (Humulin U and Humulin L) insulins.

World-wide insulin sales reached $4.7 billion in 2003, according to analysts from SG Cowen Securities Corporation, a U.S. securities and investment banking firm focused on the emerging growth sectors of health care and other markets. They reported this at a March 2004 investment conference in Boston last week, according to Kelly Close in Diabetes Close Up, V3, #6 March 17, 2004. Her website is and Markets Ltd valued the world market for human insulin at $4.5 billion in 2002. Europe accounted for 40 percent of the market and the U.S. for 33 percent. They expect the world market to reach $7.9 billion by 2007.

In the U.S. Lilly had an 86 percent share of the retail pharmacy market in 1999 compared to Novo's 14 percent. But Lilly's share drops to 78 percent when you factor in insulin use in hospitals and elsewhere where prescriptions aren't required. Only these two companies manufactured insulin sold in the United States in 1999, although Aventis subsequently took the market by storm with its introduction of very long-acting Lantus insulin.

In the United Kingdom there is a relatively minor insulin manufacturer, CP Pharmaceuticals, which Wockhardt Ltd. recently purchased. This company also exports its insulins, including porcine and bovine insulin, to people in the United States on a personal use basis. The URL is

Brasil is another country with its own source of insulin, Biobrás. Insulin was formerly manufactured in India by Boots Pharmaceuticals, which Knoll Pharmaceuticals Ltd. purchased in 1995. But Knoll apparently no longer manufactures insulin.

In Argentina, Laboratorios Beta manufactures Betasint, bovine and porcine insulin and Betalin, human insulin.

India now also has two or more companies that manufactures insulin there. Wockhardt Limited produces recombinant human insulin. The Indian press reports that Shreya Life Sciences Pvt Ltd in Mumbai (formerly Bombay) has launched recombinant human insulin under the brand name Recosulin. Further, in August 2004 Biocon's recombinant human insulin was expected to be on the market in three months.

Diosynth, an Akzo Nobel business unit, is a leading manufacturer of insulin, but does not sell it to consumers.

Two companies in Poland, Polfa Tarchomin and Bioton, manufacture human insulin, according to The Warsaw Business Journal.

Courtesy: David Mendosa, Writer